Deaths, mass illness follow Chloroquine distribution in Andhra Pradesh

Health authorities in Andhra Pradesh are investigating a public health incident in Polavaram district where the antimalarial drug Chloroquine has been linked to a fatality and a mass illness outbreak. The death of a young child and subsequent cases of sickness among multiple individuals have triggered immediate scrutiny into how the medication was administered and distributed to the local population.

Chloroquine, a long-established treatment for malaria, has been a cornerstone of disease prevention programmes across India for decades. However, the incident in Polavaram has underscored critical gaps in administration protocols and safety oversight. Preliminary reports suggest lapses in dosage calculation, storage conditions, or distribution procedures may have contributed to the adverse outcomes, though investigations remain ongoing.

The outbreak has prompted local health officials to suspend further Chloroquine distribution pending a comprehensive review of safety procedures. Affected individuals have been provided medical treatment, while authorities work to determine whether the illnesses stem from incorrect dosage, contamination, or other factors related to drug handling.

Experts have stressed the importance of stringent protocols when administering antimalarial drugs, particularly in remote districts where healthcare infrastructure may be limited. The incident highlights the need for enhanced training of healthcare workers and robust quality control measures in disease prevention programmes across the region.